# A Study of SKB571 Combination Therapy in Participants With Non-Small Cell Lung Cancer (NSCLC)

> clinical trial · VERIFIED · 2026-06-03

Status: NOT_YET_RECRUITING · Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · Condition: Non-Small Cell Lung Cancer

- Company: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07622186

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED.
